This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raycroft, L Articles by Lozano, G Search for Related Content PubMed PubMed Citation Articles by Raycroft, L Articles by Lozano, G

Analysis of p53 mutants for transcriptional activity.

Department of Molecular Genetics, University of Texas M.D. Anderson Cancer Center, Houston 77030.

ABSTRACT

The wild-type p53 protein functions to suppress transformation, but numerous mutant p53 proteins are transformation competent. To examine the role of p53 as a transcription factor, we made fusion proteins containing human or mouse p53 sequences fused to the DNA binding domain of a known transcription factor, GAL4. Human and mouse wild-type p53/GAL4 specifically transactivated expression of a chloramphenicol acetyltransferase reporter in HeLa, CHO, and NIH 3T3 cells. Several mutant p53 proteins, including a mouse p53 mutant which is temperature sensitive for suppression, were also analyzed. A p53/GAL4 fusion protein with this mutation was also transcriptionally active only at the permissive temperature. Another mutant p53/GAL4 fusion protein analyzed mimics the mutation inherited in Li-Fraumeni patients. This fusion protein was as active as wild-type p53/GAL4 in our assay. Two human p53 mutants that arose from alterations of the p53 gene in colorectal carcinomas were 30- to 40-fold less effective at activating transcription than wild-type p53/GAL4 fusion proteins. Thus, functional wild-type p53/GAL4 fusion proteins activate transcription, while several transformation competent mutants do so poorly or not at all. Only one mutant p53/GAL4 fusion protein remained transcriptionally active.

This article has been cited by other articles:

• Murph, M. M., Hurst-Kennedy, J., Newton, V., Brindley, D. N., Radhakrishna, H. (2007). Lysophosphatidic Acid Decreases the Nuclear Localization and Cellular Abundance of the p53 Tumor Suppressor in A549 Lung Carcinoma Cells. Mol Cancer Res 5: 1201-1211 [Abstract] [Full Text]  
• Hernandez, I., Maddison, L. A., Wei, Y., DeMayo, F., Petras, T., Li, B., Gingrich, J. R., Rosen, J. M., Greenberg, N. M. (2003). Prostate-Specific Expression of p53R172L Differentially Regulates p21, Bax, and mdm2 to Inhibit Prostate Cancer Progression and Prolong Survival. Mol Cancer Res 1: 1036-1047 [Abstract] [Full Text]  
• Ruiz-Ruiz, C., Robledo, G., Cano, E., Redondo, J. M., Lopez-Rivas, A. (2003). Characterization of p53-mediated Up-regulation of CD95 Gene Expression upon Genotoxic Treatment in Human Breast Tumor Cells. J. Biol. Chem. 278: 31667-31675 [Abstract] [Full Text]  
• Ghioni, P., Bolognese, F., Duijf, P. H. G., van Bokhoven, H., Mantovani, R., Guerrini, L. (2002). Complex Transcriptional Effects of p63 Isoforms: Identification of Novel Activation and Repression Domains{dagger}. Mol. Cell. Biol. 22: 8659-8668 [Abstract] [Full Text]  
• Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L. W., Sun, Y. (1999). Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53. J. Biol. Chem. 274: 12061-12066 [Abstract] [Full Text]  
• Di Como, C. J., Gaiddon, C., Prives, C. (1999). p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells. Mol. Cell. Biol. 19: 1438-1449 [Abstract] [Full Text]  
• Hao, M., Lowy, A. M., Kapoor, M., Deffie, A., Liu, G., Lozano, G. (1996). Mutation of Phosphoserine 389Affects p53 Function in Vivo. J. Biol. Chem. 271: 29380-29385 [Abstract] [Full Text]  
• Friedlander, P., Legros, Y., Soussi, T., Prives, C. (1996). Regulation of Mutant p53 Temperature-sensitive DNA Binding. J. Biol. Chem. 271: 25468-25478 [Abstract] [Full Text]  
• Hsu, Y.-S., Tang, F.-M., Liu, W.-L., Chuang, J.-Y., Lai, M.-Y., Lin, Y.-S. (1995). Transcriptional Regulation by p53. J. Biol. Chem. 270: 6966-6974 [Abstract] [Full Text]  
• Cho, Y, Gorina, S, Jeffrey, P., Pavletich, N. (1994). Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355 [Abstract]  
• Lin, J, Chen, J, Elenbaas, B, Levine, A J (1994). Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.. Genes Dev. 8: 1235-1246 [Abstract]  
• Bargonetti, J, Manfredi, J J, Chen, X, Marshak, D R, Prives, C (1993). A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.. Genes Dev. 7: 2565-2574 [Abstract]  
• Wang, Y, Reed, M, Wang, P, Stenger, J E, Mayr, G, Anderson, M E, Schwedes, J F, Tegtmeyer, P (1993). p53 domains: identification and characterization of two autonomous DNA-binding regions.. Genes Dev. 7: 2575-2586 [Abstract]  
• Zambetti, G P, Bargonetti, J, Walker, K, Prives, C, Levine, A J (1992). Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.. Genes Dev. 6: 1143-1152 [Abstract]  
• Kern, S., Pietenpol, J., Thiagalingam, S, Seymour, A, Kinzler, K., Vogelstein, B (1992). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256: 827-830 [Abstract]